# Alexion Pharmaceuticals, Inc. – FDA Inspection, Mar 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/5fb2d391-dc92-43ec-a7a3-bbb58a161055
Source feed: FDA_Inspections

> FDA inspection 1262947 of Alexion Pharmaceuticals, Inc., March 07, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262947
- Company Name: Alexion Pharmaceuticals, Inc.
- Inspection Date: 2025-03-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1330676 - 2026-07-28
- FDA Inspection 1326206 - 2026-07-01
- [FDA Inspection 1254018 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/5b301914-bf94-449d-9b3e-8f8c86990b4e)
- FDA Inspection 1219061 - 2023-09-14
- FDA Inspection 1218199 - 2023-06-30

## Related Officers

- [Meredith L. Miller](https://www.keypedia.com/people/meredith-l-miller/c775003b-4e5b-48d8-bc51-1a3ebe813dba)

Company: https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
